1. Home
  2. CLF vs KRYS Comparison

CLF vs KRYS Comparison

Compare CLF & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLF
  • KRYS
  • Stock Information
  • Founded
  • CLF 1847
  • KRYS 2015
  • Country
  • CLF United States
  • KRYS United States
  • Employees
  • CLF N/A
  • KRYS N/A
  • Industry
  • CLF Metal Mining
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLF Basic Materials
  • KRYS Health Care
  • Exchange
  • CLF Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • CLF 5.6B
  • KRYS 4.7B
  • IPO Year
  • CLF N/A
  • KRYS 2017
  • Fundamental
  • Price
  • CLF $15.70
  • KRYS $195.22
  • Analyst Decision
  • CLF Buy
  • KRYS Strong Buy
  • Analyst Count
  • CLF 11
  • KRYS 9
  • Target Price
  • CLF $11.31
  • KRYS $210.22
  • AVG Volume (30 Days)
  • CLF 35.9M
  • KRYS 302.5K
  • Earning Date
  • CLF 10-20-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • CLF N/A
  • KRYS N/A
  • EPS Growth
  • CLF N/A
  • KRYS 36.22
  • EPS
  • CLF N/A
  • KRYS 4.91
  • Revenue
  • CLF $18,457,000,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • CLF $2.18
  • KRYS $34.33
  • Revenue Next Year
  • CLF $5.13
  • KRYS $47.84
  • P/E Ratio
  • CLF N/A
  • KRYS $38.78
  • Revenue Growth
  • CLF N/A
  • KRYS 116.08
  • 52 Week Low
  • CLF $5.63
  • KRYS $122.80
  • 52 Week High
  • CLF $14.51
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • CLF 72.72
  • KRYS 71.99
  • Support Level
  • CLF $13.11
  • KRYS $186.73
  • Resistance Level
  • CLF $14.27
  • KRYS $195.91
  • Average True Range (ATR)
  • CLF 0.75
  • KRYS 6.27
  • MACD
  • CLF 0.09
  • KRYS 0.25
  • Stochastic Oscillator
  • CLF 77.68
  • KRYS 97.51

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: